scholarly article | Q13442814 |
P50 | author | Kristine Yaffe | Q18749055 |
Brenda Penninx | Q21255846 | ||
Dorly Deeg | Q46709949 | ||
Hannie C Comijs | Q93088592 | ||
Miranda G Dik | Q117231786 | ||
P2093 | author name string | Cees Jonker | |
Astrid Kok | |||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | metabolic syndrome | Q657193 |
P304 | page(s) | 2655-2660 | |
P577 | publication date | 2007-06-11 | |
P1433 | published in | Diabetes Care | Q5270111 |
P1476 | title | Contribution of metabolic syndrome components to cognition in older individuals. | |
P478 | volume | 30 |
Q36001196 | Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation |
Q36439996 | Are cardiovascular risk factors associated with verbal learning and memory impairment in patients with schizophrenia? A cross-sectional study |
Q38764886 | Association between metabolic syndrome and cognitive decline: a systematic review of prospective population-based studies |
Q42839140 | Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: the European Male Ageing Study |
Q40391922 | Association of metabolic syndrome and 25-hydroxyvitamin D with cognitive impairment among elderly Koreans |
Q55317670 | Associations between waist circumference, metabolic risk and executive function in adolescents: A cross-sectional mediation analysis. |
Q64119280 | Associations of the metabolic syndrome and its components with cognitive impairment in older adults |
Q64949344 | Beneficial Effect of Exercise on Cognitive Function during Peripheral Arterial Disease: Potential Involvement of Myokines and Microglial Anti-Inflammatory Phenotype Enhancement. |
Q34644175 | BioAge: toward a multi-determined, mechanistic account of cognitive aging |
Q35050058 | C-reactive protein is linked to lower cognitive performance in overweight and obese women |
Q37079149 | Caloric restriction improves memory in elderly humans |
Q38182056 | Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models. |
Q38879090 | Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease |
Q92447867 | Changes in Metabolic Syndrome Status and Risk of Dementia |
Q42185326 | Childhood and adolescent obesity and long-term cognitive consequences during aging. |
Q37598849 | Clinical, physical and lifestyle variables and relationship with cognition and mood in aging: a cross-sectional analysis of distinct educational groups |
Q90058371 | Cognitive Performance Among Older Persons in Japan and the United States |
Q47094631 | Cognitive assessment in an elderly population with metabolic syndrome in Brazil. |
Q43992669 | Cognitive decline and cardiometabolic risk among Hispanic and non-Hispanic white adults in the San Luis Valley Health and Aging Study |
Q37783584 | Cognitive dysfunction in patients with type 2 diabetes. |
Q37832122 | Cognitive function, dementia and type 2 diabetes mellitus in the elderly |
Q35050048 | Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance |
Q64229486 | Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis |
Q38162296 | Coupling physical exercise with dietary glucose supplement for treating cognitive impairment in schizophrenia: a theoretical model and future directions |
Q47680272 | Cross-sectional associations between metabolic syndrome and performance across cognitive domains: A systematic review. |
Q34891961 | Current serum lipoprotein levels and FMRI response to working memory in midlife. |
Q48149953 | Depressive symptoms, cognitive impairment, and metabolic syndrome in community-dwelling elderly in Southern Taiwan |
Q33943899 | Detection of mild cognitive impairment in people older than 65 years of age and its relationship to cardiovascular risk factors (DECRIVAM). |
Q31119662 | Diabetes and Cognitive Impairment |
Q37332434 | Diabetes reduces the cognitive function with the decrease of the visual perception and visual motor integration in male older adults |
Q35072195 | Disinhibited eating in obese adolescents is associated with orbitofrontal volume reductions and executive dysfunction |
Q38875190 | Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease |
Q40684556 | Effects of Posttraumatic Stress Disorder and Metabolic Syndrome on Cognitive Aging in Veterans |
Q42824364 | Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome. |
Q35810862 | Elevated serum C-reactive protein relates to increased cerebral myoinositol levels in middle-aged adults |
Q36240154 | Elevation of Serum Aminotransferase Levels and Future Risk of Death from External Causes: A Prospective Cohort Study in Korea |
Q37783543 | Encephalopathies: the emerging diabetic complications |
Q39028258 | Executive dysfunction assessed by Clock-Drawing Test in older non-demented subjects with metabolic syndrome is not mediated by white matter lesions. |
Q51026077 | Functional MR imaging evidence of altered functional activation in metabolic syndrome. |
Q50607600 | Glucose administration and cognitive function: differential effects of age and effort during a dual task paradigm in younger and older adults. |
Q38415914 | Glycemic control, inflammation, and cognitive function in older patients with type 2 diabetes |
Q36926280 | Habitual sugar intake and cognitive function among middle-aged and older Puerto Ricans without diabetes |
Q98566253 | Hippocampal electrophysiological changes during the elicited metabolic syndrome in Wistar rats |
Q36329909 | Impact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome |
Q34063614 | Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study |
Q49074834 | Metabolic Syndrome Exacerbates Short-term Postoperative Cognitive Dysfunction in Patients Undergoing Cardiac Surgery: Results of a Pilot Study |
Q40883019 | Metabolic Syndrome and Mild Cognitive Impairment: A Case-Control Study among Elderly in a Shanghai Suburb |
Q54961329 | Metabolic Syndrome and cognitive decline in the elderly: A systematic review. |
Q34351623 | Metabolic Syndrome, Brain Magnetic Resonance Imaging, and Cognition |
Q64100161 | Metabolic syndrome alters relationships between cardiometabolic variables, cognition and white matter hyperintensity load |
Q35918724 | Metabolic syndrome and 16-year cognitive decline in community-dwelling older adults |
Q36880464 | Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults |
Q37343645 | Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes |
Q33939271 | Metabolic syndrome and localization of white matter hyperintensities in the elderly population |
Q37022797 | Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study |
Q40768973 | Metabolic syndrome correlates poorly with cognitive performance in stroke-free community-dwelling older adults: a population-based, cross-sectional study in rural Ecuador |
Q33928071 | Metabolic syndrome is associated with learning and recall impairment in middle age. |
Q33556918 | Metabolic syndrome over 10 years and cognitive functioning in late midlife: the Whitehall II study |
Q30239094 | Metabolic syndrome, hypertension, and nervous system injury: Epidemiological correlates |
Q33721734 | Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study |
Q43890893 | Midlife metabolic syndrome and neurocognitive function in a mixed Asian sample. |
Q35234745 | Modeling metabolic syndrome and its association with cognition: the Northern Manhattan study |
Q26752744 | Neuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome |
Q37738402 | Neuroinflammation and cognitive aging |
Q55109555 | Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome. |
Q38680759 | Obesity and sex interact in the regulation of Alzheimer's disease |
Q36210182 | Obesity is associated with structural and functional brain abnormalities: where do we go from here? |
Q46480326 | Osteocalcin as a predictor of the metabolic syndrome in older persons: a population-based study. |
Q92189390 | Physical activity is associated with better global cognition and frontal function in overweight/obese older adults with metabolic syndrome |
Q37703791 | Prevalence of metabolic syndrome in elderly and agreement among four diagnostic criteria |
Q64912462 | Preventive Effects of Dairy Products on Dementia and the Underlying Mechanisms. |
Q33544151 | Promoting successful cognitive aging: a comprehensive review |
Q36611401 | Relationship between Insulin-Resistance Processing Speed and Specific Executive Function Profiles in Neurologically Intact Older Adults |
Q92910807 | Risk of dementia and cognitive dysfunction in individuals with diabetes or elevated blood glucose |
Q34365458 | Role of standardized grape polyphenol preparation as a novel treatment to improve synaptic plasticity through attenuation of features of metabolic syndrome in a mouse model |
Q41657238 | Severity of hypertension predicts the generalized neurocognitive deficit in schizophrenia |
Q35042613 | Sex differences in the association between muscle quality, inflammatory markers, and cognitive decline |
Q36733926 | Subclinical vascular disease and cerebral glutamate elevation in metabolic syndrome |
Q58610974 | TLR4 inhibitor TAK-242 attenuates the adverse neural effects of diet-induced obesity |
Q33737263 | The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease |
Q35546438 | The metabolic syndrome and cognitive performance: the Northern Manhattan Study |
Q37200520 | The metabolic syndrome and development of cognitive impairment among older women |
Q43166484 | The relationship between adult neuropsychological profiles and diabetic patients' glycemic control |
Q60303127 | Validation of a single factor representing the indicators of metabolic syndrome as a continuous measure of metabolic load and its association with health and cognitive function |
Q59050557 | Vascular Functions and Brain Integrity in Midlife: Effects of Obesity and Metabolic Syndrome |
Q34786103 | Vascular risk factors, alcohol intake, and cognitive decline. |
Q36812802 | Vascular risk factors, cognitive decline, and dementia |
Q42026475 | Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease |
Q33642287 | White matter fractional anisotropy is related to processing speed in metabolic syndrome patients: a case-control study |